Alibaba Health Information Technology Limited (ALBHF)
OTCMKTS
· Delayed Price · Currency is USD
0.6660
0.00 (0.00%)
May 22, 2025, 4:00 PM EDT
ALBHF Income Statement
Financials in millions CNY. Fiscal year is April - March.
Millions CNY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 30,598 | 27,027 | 26,763 | 20,578 | 15,518 | Upgrade
|
| Revenue Growth (YoY) | 13.22% | 0.98% | 30.06% | 32.60% | 61.71% | Upgrade
|
| Cost of Revenue | 23,166 | 21,131 | 21,062 | 16,470 | 11,901 | Upgrade
|
| Gross Profit | 7,432 | 5,895 | 5,701 | 4,108 | 3,617 | Upgrade
|
| Selling, General & Admin | 5,234 | 4,550 | 5,055 | 4,474 | 3,135 | Upgrade
|
| Research & Development | 720.05 | 705.38 | 677.82 | 728.83 | 423.63 | Upgrade
|
| Other Operating Expenses | 24.91 | 5.33 | 19.72 | 3.95 | 21.08 | Upgrade
|
| Operating Expenses | 5,978 | 5,260 | 5,753 | 5,206 | 3,580 | Upgrade
|
| Operating Income | 1,454 | 634.85 | -51.5 | -1,098 | 37.47 | Upgrade
|
| Interest Expense | -2.61 | -5.97 | -5.83 | -3.82 | -2.45 | Upgrade
|
| Interest & Investment Income | 488.57 | 508.56 | 331.59 | 213.58 | 166.78 | Upgrade
|
| Earnings From Equity Investments | -64.66 | -5.93 | 11.38 | -45.62 | -38.41 | Upgrade
|
| Currency Exchange Gain (Loss) | -37.14 | 7.09 | 72.06 | 39.7 | 32.42 | Upgrade
|
| Other Non Operating Income (Expenses) | 121.02 | 92.17 | 99.17 | 102.54 | 69.15 | Upgrade
|
| EBT Excluding Unusual Items | 1,959 | 1,231 | 456.86 | -792.05 | 264.95 | Upgrade
|
| Gain (Loss) on Sale of Investments | -399.45 | -283.44 | 114.89 | 542.1 | 65.74 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.62 | 0.53 | -1.24 | 0.14 | 70.53 | Upgrade
|
| Other Unusual Items | - | -8.46 | -19.51 | -2.71 | - | Upgrade
|
| Pretax Income | 1,560 | 939.4 | 550.99 | -252.51 | 401.22 | Upgrade
|
| Income Tax Expense | 127.95 | 56.26 | 14.49 | 13.43 | 58.54 | Upgrade
|
| Earnings From Continuing Operations | 1,432 | 883.14 | 536.51 | -265.94 | 342.68 | Upgrade
|
| Minority Interest in Earnings | 0.41 | 0.34 | -0.86 | 0.39 | 5.91 | Upgrade
|
| Net Income | 1,432 | 883.48 | 535.65 | -265.56 | 348.59 | Upgrade
|
| Net Income to Common | 1,432 | 883.48 | 535.65 | -265.56 | 348.59 | Upgrade
|
| Net Income Growth | 62.13% | 64.94% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 16,071 | 14,044 | 13,503 | 13,483 | 13,246 | Upgrade
|
| Shares Outstanding (Diluted) | 16,136 | 14,091 | 13,542 | 13,483 | 13,327 | Upgrade
|
| Shares Change (YoY) | 14.51% | 4.06% | 0.44% | 1.17% | 11.69% | Upgrade
|
| EPS (Basic) | 0.09 | 0.06 | 0.04 | -0.02 | 0.03 | Upgrade
|
| EPS (Diluted) | 0.09 | 0.06 | 0.04 | -0.02 | 0.03 | Upgrade
|
| EPS Growth | 41.63% | 58.33% | - | - | - | Upgrade
|
| Free Cash Flow | 1,395 | 1,057 | 250.08 | 409.43 | 992.35 | Upgrade
|
| Free Cash Flow Per Share | 0.09 | 0.07 | 0.02 | 0.03 | 0.07 | Upgrade
|
| Gross Margin | 24.29% | 21.81% | 21.30% | 19.96% | 23.31% | Upgrade
|
| Operating Margin | 4.75% | 2.35% | -0.19% | -5.34% | 0.24% | Upgrade
|
| Profit Margin | 4.68% | 3.27% | 2.00% | -1.29% | 2.25% | Upgrade
|
| Free Cash Flow Margin | 4.56% | 3.91% | 0.93% | 1.99% | 6.40% | Upgrade
|
| EBITDA | 1,486 | 658.74 | -24.48 | -1,077 | 52.14 | Upgrade
|
| EBITDA Margin | 4.86% | 2.44% | -0.09% | -5.23% | 0.34% | Upgrade
|
| D&A For EBITDA | 32.13 | 23.89 | 27.03 | 21.88 | 14.67 | Upgrade
|
| EBIT | 1,454 | 634.85 | -51.5 | -1,098 | 37.47 | Upgrade
|
| EBIT Margin | 4.75% | 2.35% | -0.19% | -5.34% | 0.24% | Upgrade
|
| Effective Tax Rate | 8.20% | 5.99% | 2.63% | - | 14.59% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.